All PF-07321332 articles
-
Business
Covid-19 antivirals surge forward
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir
2021-11-12T14:17:00Z
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir
Site powered by Webvision Cloud